Data gathered: November 17
AI Stock Analysis - CVRx (CVRX)
Analysis generated November 16, 2024. Powered by Chat GPT.
CVRx, Inc. is a medical device company specializing in innovative solutions for cardiovascular diseases. The company’s flagship product, Barostim Neo™, is designed to improve the quality of life for patients suffering from heart failure and other related conditions. Headquartered in Minneapolis, Minnesota, CVRx aims to leverage advanced technology to provide effective and minimally invasive treatments. As the company continues to expand its market reach and product offerings, it is crucial to analyze its financial health, stock performance, and other relevant metrics.
Stock Alerts - CVRx (CVRX)
 |
CVRx | November 16 Youtube Subscribers are up by 4.5% in the last 24h. |
|
CVRx | November 15 Youtube Subscribers are up by 4.7% in the last 24h. |
|
CVRx | November 14 Youtube Subscribers are up by 2.4% in the last 24h. |
|
CVRx | November 13 Price is down by -5.3% in the last 24h. |
Alternative Data for CVRx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 9 | Sign up | Sign up | Sign up |
| Sentiment | 10 | Sign up | Sign up | Sign up |
| Webpage traffic | 13,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 32 | Sign up | Sign up | Sign up |
| Patents | 15 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,578 | Sign up | Sign up | Sign up |
| Instagram Followers | 370 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 721 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,008 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,400 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 86 | Sign up | Sign up | Sign up |
| Linkedin Employees | 245 | Sign up | Sign up | Sign up |
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
| Price | $13.91 |
| Target Price | Sign up |
| Volume | 155,190 |
| Market Cap | $338M |
| Year Range | $6.49 - $21.87 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
 |
CVRx Announces Approval of Barostim Procedure for New Technology Ambulatory Payment ClassificationNovember 8 - ETF Daily News |
 |
CVRx: Impressive Top-Line Growth Seems Priced InNovember 6 - SeekingAlpha |
 |
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025November 3 - Yahoo |
 |
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next YearOctober 31 - Yahoo |
CVRX Crosses Above Average Analyst TargetOctober 30 - ETF Channel |
|
 |
Canaccord Genuity Group Increases CVRx (NASDAQ:CVRX) Price Target to $17.00October 30 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 13M | 2.2M | 11M | -13M | -16M | -0.570 |
| Q2 '24 | 12M | 1.9M | 9.9M | -14M | -14M | -0.650 |
| Q1 '24 | 11M | 1.6M | 9.2M | -22M | -22M | -1.040 |
| Q4 '23 | 11M | 1.7M | 9.6M | -9.2M | -8.4M | -0.440 |
| Q3 '23 | 11M | 1.7M | 8.8M | -9M | -8.5M | -0.430 |
Insider Transactions View All
| SLATTERY JOSEPH P filed to buy 30,645 shares at $8.1. August 15 '24 |
| SLATTERY JOSEPH P filed to buy 27,645 shares at $8.2. August 8 '24 |
| SLATTERY JOSEPH P filed to buy 24,645 shares at $9.1. August 6 '24 |
| Hykes Kevin filed to buy 30,000 shares at $8.4. August 5 '24 |
| VERRASTRO PAUL filed to sell 2,455 shares at $21.9. February 22 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$86.99 0% | 62 |
 |
Edwards LifesciencesEW |
$67.76 0% | 47 |
 |
Intuitive SurgicalISRG |
$527.61 0% | 73 |
 |
MedtronicMDT |
$87.53 0% | 60 |
 |
StrykerSYK |
$390.08 0% | 70 |
Read more about CVRx (CVRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of CVRx?
The Market Cap of CVRx is $338M.
What is the current stock price of CVRx?
Currently, the price of one share of CVRx stock is $13.91.
How can I analyze the CVRX stock price chart for investment decisions?
The CVRX stock price chart above provides a comprehensive visual representation of CVRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling CVRx shares. Our platform offers an up-to-date CVRX stock price chart, along with technical data analysis and alternative data insights.
Does CVRX offer dividends to its shareholders?
As of our latest update, CVRx (CVRX) does not offer dividends to its shareholders. Investors interested in CVRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of CVRx?
Some of the similar stocks of CVRx are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.